FDA’s final rule on citizen petitions makes only minor revisions to its proposed regulation, most notably shortening the agency’s response time from 180 days to 150 days.
The document instead is largely devoted to rejecting suggestions by the Pharmaceutical Research and Manufacturers of America to alter the...